Biodesix
Uses multi-omic testing to address clinical questions in lung disease.
$26.83
After-hours close+0.06 (+0.22%)
At close$26.77(−6.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 44.41%3.62M sharesInsiders 10.08%820.3K sharesOther 45.51%3.70M shares
Shares outstanding 8.14M · Float 4.66M · 57.2% free float
Institutions13F, as of Mar 31, 2026
41 holders · 3.62M shares · 24 new positions · 31 increased · 2 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Aigh Capital Management LLC | 758.3K | 9.32% | +758.3Knew | Apr 30, 2026 |
| Telemark Asset Management, LLC | 489.8K | 6.02% | +162.0K | May 12, 2026 |
| Abrdn PLC | 458.4K | 5.63% | +196.0K | Apr 29, 2026 |
| Soleus Capital Management, L.P. | 416.6K | 5.12% | +416.6Knew | May 14, 2026 |
| Vanguard Capital Management LLC | 255.2K | 3.13% | +255.2Knew | May 15, 2026 |
| Opaleye Management Inc. | 238.0K | 2.92% | +238.0Knew | May 15, 2026 |
| Marshall Wace, LLP | 141.6K | 1.74% | +141.6Knew | May 15, 2026 |
| Essex Investment Management Co LLC | 132.1K | 1.62% | +132.1Knew | May 11, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Schuler Jack Wincl. Jack W. Schuler 2025 GRAT, Jack W. Schuler Living Trust | 26.00% | 13D | Sep 3, 2025 ↗ | |
| Orin Hirschman | 7.70% | 758.3K | 13G | Apr 28, 2026 ↗ |
| Telemark Asset Management, LLC | 5.40% | 427.8K | 13G | Jan 26, 2026 ↗ |
| Soleus Capital Master Fund, L.P. | 5.10% | 525.2K | 13G | Jun 18, 2026 ↗ |
| Perceptive Advisors LLC | 5.10% | 13G | May 15, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Jack W. Schuler | 10 percent owner, other: Emeritus Director | 555.8K | 6.83% | Aug 13, 2026 |
| John Patience | director, other: Chairman | 133.0K | 1.63% | Jul 2, 2026 |
| Scott Hutton | director, officer: President & CEO | 48.8K | 0.60% | Feb 23, 2026 |
| Charles M. Watts | director | 21.1K | 0.26% | Apr 2, 2025 |
| Hany Massarany | director | 18.2K | 0.22% | Jul 2, 2025 |
| Robin Harper Cowie | officer: CFO, Sec'y & Treasurer | 16.2K | 0.20% | Feb 23, 2026 |
| Gary Anthony Pestano | officer: Chief Development Officer | 10.4K | 0.13% | Feb 23, 2026 |
| Kieran O'Kane | officer: Chief Commercial Officer | 9.8K | 0.12% | Feb 23, 2026 |
| Jean M. Franchi | director | 5.4K | 0.07% | Apr 2, 2025 |
| Chris Vazquez | officer: Chief Accounting Officer | 1.6K | 0.02% | Feb 23, 2026 |
5 people have not refiled in the last 18 months (538.0K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Jack W. Schuler10 percent owner, other: Emeritus Director | Purchase | 15,000 | $24.47 | 555,810 |
| Aug 11, 2026 | Jack W. Schuler10 percent owner, other: Emeritus Director | Purchase | 13,700 | $24.01 | 540,810 |
| Aug 10, 2026 | Jack W. Schuler10 percent owner, other: Emeritus Director | Purchase | 13,900 | $24.25 | 527,110 |
| Feb 23, 2026 | Scott Huttondirector, officer: President & CEO | Sale | 1,490 | $12.78 | 48,767 |
| Feb 23, 2026 | Chris Vazquezofficer: Chief Accounting Officer | Sale | 211 | $12.78 | 1,586 |
| Feb 23, 2026 | Robin Harper Cowieofficer: CFO, Sec'y & Treasurer | Sale | 535 | $12.78 | 16,231 |
| Feb 23, 2026 | Kieran O'Kaneofficer: Chief Commercial Officer | Sale | 535 | $12.78 | 9,819 |
| Feb 23, 2026 | Gary Anthony Pestanoofficer: Chief Development Officer | Sale | 556 | $12.78 | 10,359 |
| Feb 10, 2026 | Gary Anthony Pestanoofficer: Chief Development Officer | Sale | 540 | $10.08 | 9,387 |
| Feb 10, 2026 | Robin Harper Cowieofficer: CFO, Sec'y & Treasurer | Sale | 941 | $10.08 | 15,297 |
CongressHouse and Senate disclosures
Not reported.